Abstract
This chapter discusses how, when antidepressants were discovered, neurotransmitters and the mechanism of neurotransmission in the brain were also being discovered. In the laboratory, experimental models in vitro showed that tricyclic antidepressants inhibited the synaptic reuptake of norepinephrine and serotonin . This finding gave origin to the seductive theory that depression was the result of a chemical unbalance, with reduced concentrations of the neurotransmitters in the brain synapses, which were corrected by the drug. With the introduction of selective serotonin reuptake inhibitors such as Prozac the theory was refocused specifically on serotonin. Yet no direct evidence has ever been provided regarding in vivo conditions in real patients. Additionally, clinical evidence such as the latency of the response and the lack of activity in about one-third of patients treated remains unexplained.
A specialist is a man who knows more and more about less and less.
William J. Mayo
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
aan het Rot, M., Mathew, S. J., & Charney, D. S. (2009). Neurobiological mechanisms in major depressive disorder. Canadian Medical Association Journal, 180(3), 305–313.
Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.
Baughman, F. (2006). There is no such thing as a psychiatric disorder/ disease/chemical imbalance. PLoS Med, 3(7), e318.
Baumeister, A. A., Hawkins, M. F., & Uzelac, S. M. (2003). The myth of the reserpine—Induced depression: Role in the historical development of the monoamine hypothesis. Journal of the History of Neurosciences, 12(2), 207–220.
Beers, M. H., & Passman, L. J. (1990). Antihypertensive medications and depression. Drugs, 40(6), 792–799.
Belmaker, R. H., & Agam, G. (2008). Major depressive disorder. New England Journal of Medicine, 358, 55–68.
Benarroch, E. E. (2009). The locus ceruleus norepinephrine system: Functional organization and potential clinical significance. Neurology, 73(20), 1699–1704.
Bennett, M. R. (1998). Monoaminergic synapses and schizophrenia: 45 years of neuroleptics. Journal of Psychopharmacology, 12, 289–304.
Berger, M., Gray, J. A., & Roth, B. L. (2009). The expanded biology of serotonin. Annual Reviews of Medicine, 60, 355–366.
Berton, O., & Nestler, E. J. (2006). New approaches to antidepressant drug discovery: Beyond monoamines. Nature Reviews Neuroscience, 7, 137–151.
Bowers, M. B. (1974). Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes. Journal of Nervous and Mental Diseases, 158(5), 325–330.
Bowers, M. B., Heninger, G. R., & Gerbode, F. (1969). Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients. International Journal of Neuropharmacology, 8(3), 255–262.
Brink, C. B., Harvey, B. H., & Brand, L. (2006). Tianeptine: A novel atypical antidepressant that may provide new insights into the biomolecular basis of depression. Recent Patents on CNS Drug Discovery, 1(1), 29–41.
Castrén, E. (2005). Is mood chemistry? Nature Reviews Neurosciences, 6(3), 241–246.
Castrén, E., & Rantamaki, T. (2010). The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Developmental Neurobiology, 70(5), 289–297.
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., Tansella, M., & Barbui, C. (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis. Lancet, 73, 746–758.
Davies, D. L., & Shepherd, M. (1955). Reserpine in the treatment of anxious and depressed patients. Lancet, 269(6881), 117–120.
Delgado, P., & Moreno, F. (2000). Role of norepinephrine in depression. Journal of Clinical Psychiatry, 61(1), 5–12.
Delgado, P. L., Price, L. H., Miller, H. L., Salomon, R. M., Aghajanian, G. K., Heninger, G. R., & Charney D. S. (1994). Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Archives of General Psychiatry, 51(11), 865–874.
Dubvosky, S., Davies, R., & Dubvosky, A. (2003). Mood disorders. In R. Yudofsky & S. Hales (Eds.), The american psychiatric textbook of clinical psychiatry (pp. 439–542). Washington, DC: American Psychiatric Press.
Eyding, D., Lelgemann, M., Grouven, U., Härter, M., Kromp, M., Kaiser, T., Kerekes, M. F., Gerken, M., & Wieseler, B. (2010). Reboxetine for acute treatment of major depression: Systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. British Medical Journal, 341, c4737.
Glowinski, J., & Axelrod, J. (1964). Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature, 204, 1318–1319.
Hammen, C. (2005). Stress and depression. Annual Review of Clinical Psychology, 1, 293–319.
Hasler, G. (2010). Pathophysiology of depression: Do we have any solid evidence of interest to clinicians? World Psychiatry, 9, 155–161.
Healy, D. (2004). Let them eat prozac: The unhealthy relationship between the pharmaceutical companies and depression. New York: New York University Press.
Herzberg, D. (2009). Happy pills in America: From miltown to prozac. Baltimore: John Hopkins University Press.
Horgan, J. (1999). The undiscovered mind: How the human brain defies replication, medication, and explanation. New York: Free Press.
Horwitz, A. V., & Wakefield, J. C. (2012). All we have to fear: Psychiatry’s transformation of natural anxieties into mental disorders. Oxford: Oxford University Press.
Humble, M. (2000). Noradrenaline and serotonin reuptake inhibition as clinical principles: A review of antidepressant efficacy. Acta Psychiatrica Scandinavica, 101(Suppl. 402), 28–36.
Ig Nobel Prize. (2000). May we recommend—The science of romantic love. http://www.improb.com/news/2002/feb/romantic.html. Accessed 15 April, 2015.
Karch, S. B. (1999). Cocaine: History, use, abuse. Journal of the Royal Society of Medicine, 92(8), 393–397.
Lacasse, J. R., & Leo, J. (2005). Serotonin and depression: A disconnect between the advertisements and the scientific literature. PLoS Med, 2(12), e392.
Lahti, R. A., & Maickel, R. P. (1971). The tricyclic antidepressants-inhibition of norepinephrine uptake as related to potentiation of norepinephrine and clinical efficacy. Biochemical Pharmacology, 20(2), 482–486.
Leo, J., & Lacasse, J. R. (2008). The media and the chemical imbalance theory of depression. Society, 45(1), 35–45.
Leucht, C., Huhn, M., & Leucht, S. (2012). Amitriptyline versus placebo for major depressive disorder. Cochrane Database of Systematic Reviews, (2). doi: 10.1002/14651858.
López-Muñoz, F., & Alamo, C. (2009a). Historical evolution of the neurotransmission concept. Journal of Neural Transmission, 116(5), 515–533.
López-Muñoz, F., & Alamo, C. (2009b). Monoaminergic neurotransmission: The history of the discovery of antidepressants from 1950s until today. Current Pharmaceutical Design, 15(14), 1563–1586.
Maas, J. W., Koslow, S. H., Katz, M. M., et al. (1984). Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. American Journal of Psychiatry, 14(10), 1159–1171.
Magarian, G. J. (1991). Reserpine: A relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension? Journal of General and Internal Medicine, 6(6), 561–572.
Mahara, I., Bambicoc, F. C., Mechawara, N., & Nobrega, J. N. (2014). Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neuroscience and Biobehavioral Reviews, 38, 173–192.
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001). The cellular neurobiology of depression. Nature Medicine, 7, 541–547.
Marazziti, D., Akiskal, H. S., Rossi, A., & Cassano, G. B. (1999). Alteration of the platelet serotonin transporter in romantic love. Psychological Medicine, 29(3), 741–745.
McEwen, B. S., Chattarji, S., Diamond, D. M., Jay, T. M., Reagan, L. P., Svenningsson, P., & Fuchs, E. (2010). The neurobiological properties of tianeptine (Stablon): From monoamine hypothesis to glutamatergic modulation. Molecular Psychiatry, 15(3), 237–249.
McGeer, P. L., & McGeer, E. G. (1980). Chemistry of mood and emotion. Annual Reviews of Psychology, 31, 273–307.
Mendels, J., & Frazer, A. (1974). Brain biogenic amine depletion and mood. Archives of Genral Psychiatry, 30(4), 447–451.
Moncrieff, J. (2007). The myth of the chemical cure: A critique of psychiatric drug treatment. Basingstoke: Palgrave Macmillan.
Mulinari, S. (2012). Monoamine theories of depression: Historical impact on biomedical research. Journal of the History of the Neurosciences: Basic and Clinical Perspectives, 21(4), 366–392.
Nestler, E.J., Barrot, M., DiLeone, R.J. Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002). Neurobiology of Depression. Neuron, 34(1): 13–25.
Nobel Prize in Physiology and Medicine. (1936).http://www.nobelprize.org/nobel_prizes/medicine/laureates/1936/. Accessed 3 February, 2015.
Nobel Prize in Physiology and Medicine. (1970). http://www.nobelprize.org/nobel_prizes/medicine/laureates/1970/. Accessed March 3, 2015.
Papeschi, R., & McClure, D. J. (1971). Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. Archives of General Psychiatry, 25(4), 354–358.
Paykel, E. S., Myers, J. K., Dienelt, M. N., Klerman, G. L., Lindenthal, J. J., & Pepper, M. P. (1969). Life events and depression: A controlled study. Archives of General Psychiatry, 21(6), 753–760.
Racagni, G., & Popoli, M. (2008). Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues in Clinical Neurosciences, 10(4), 385–400.
Rasmussen, R. (2008). A quantitative and qualitative retrospective with implications for the present America’s first amphetamine epidemic 1929–1971. American Journal of Public Health, 98(6), 974–985.
Ravindran, A. V., & da Silva, T. L. (2013). Review complementary and alternative therapies as add-onto pharmacotherapy for mood and anxiety disorders: A systematic review. Journal of Affective Disorders, 150(3), 707–719.
Ross, S. B., & Renyi, A. L. (1967). Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. European Journal of Pharmacology, 2(3), 181–186.
Ross, S. B., & Renyi, A. L. (1969). Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. European Journal of Pharmacology, 7(3), 270–277.
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla J. S. (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse, 39(1), 32–41.
Ruetsch, Y. A., Boni, T., & Borgeat, A. (2001). From cocaine to ropivacaine: The history of local anesthetic drugs. Current Topics in Medicinal Chemistry, 1(3), 175–182.
Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: A review of the supportive evidence. American Journal of Psychiatry, 122(5), 509–522.
Slattery, D. A., Hudson, A. L., & Nutt, D. J. (2004). Invited review: The evolution of antidepressant mechanisms. Fundamental & Clinical Pharmacology, 18(1), 1–21.
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005). Mechanisms of neurotransmitter release by amphetamines: A review. Progress in Neurobiology, 75(6), 406–433.
Svensson, T. H. (2000). Brain noradrenaline and the mechanisms of action of antidepressant drugs. Acta Psychiatrica Scandinavica, 402(Suppl. 2000) 18–27.
Valenstein, E. S. (1998). Blaming the brain: The truth about drugs and mental health. New York: Free Press.
Willner, P., Scheel-Krügerb, J., & Belzung, C. (2013). The neurobiology of depression and antidepressant action. Neuroscience and Biobehavioral Reviews, 37(10 Part 1): 2331–2371.
Wong, D. T., Perry, K. W., & Bymaster, F. P. (2005). The discovery of fluoxetine hydrochloride (Prozac). Nature Reviews Drug Discovery, 4, 764–774.
Wrobel, S. (2007). Science, serotonin, and sadness: The biology of antidepressants. The FASEB Journal, 21(13), 3404–3417.
Young, L. J. (2009). Being human: Love: Neuroscience reveals all. Nature, 457(7226), 148. doi:10.1038/457148a.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 The Author(s)
About this chapter
Cite this chapter
Giraldi, T. (2017). A Matter of Chemistry. In: Unhappiness, Sadness and 'Depression'. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-319-57657-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-57657-2_9
Published:
Publisher Name: Palgrave Macmillan, Cham
Print ISBN: 978-3-319-57656-5
Online ISBN: 978-3-319-57657-2
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)